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Pleural effusion is an accumulation of pleural fluid that can appear in patients with 
congestive cardiac failure, pneumonia, tuberculosis, pulmonary embolism, cancer 
(mainly lung and breast cancer), or physical trauma. Therefore, a cytologic study is 
commonly needed to confirm the etiology of this malignancy, and in a relevant number 
of patients surgical techniques are also required. Although several studies have been 
performed on pleural effusion, their purpose were more a description of the protein 
content than a comparative analysis to discriminate differentially expressed proteins. 
For this reason, the aim of this work was to find new protein biomarkers that could 
improve the diagnosis of malignant pleural effusions in order to avoid the use of 
invasive diagnostic procedures.
We have compared, by means of proteomic techniques, pleural effusion samples 
from four patients with tuberculous pleural effusion and four patients with non-small 
cell lung cancer. Since large portions of pleural effusion proteins are common to those 
found in plasma, we performed a previous fractionation of samples using multiple 
affinity removal spin cartridges for the depletion of six high-abundant proteins (Agilent 
technologies) in order to detect low abundance proteins that could serve as novel 
biomarkers for the malignancy.
After depletion, to test the efficiency of the removal process, a global analysis of 
pleural effusion proteome was made using conventional two-dimensional electrophoresis 
(2-DE). Gels were silver-stained and analyzed using PDQuest software, revealing more 
than 1200 spots per gel.
Comparison of proteomes from neoplasic origin versus benign ones was carried 
out using two-dimensional differential in-gel electrophoresis (2D-DIGE) technology 
and analyses of differences were made with Decyder Software. Those proteins 
presenting statistical significant differences will be submitted to mass spectrometry for 
identification.
